All That Matters
The aim of European Urology Focus (EU Focus) is to encompass the whole spectrum of urology. The journal publishes papers on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcomes basic and translational research articles in the field of urological diseases.
Besides original research articles and systematic reviews, which are the backbone of the journal, EU Focus publishes "Point of Focus" debates which cover controversial topics from a pro/con standpoint. The journal also publishes "Clinical Trial Updates" focusing on an ongoing trial, and the "Grey Zone", which sheds light on areas for which guideline recommendations are difficult to make, because of the absence of data. In addition, the "Clinical Consultation Guide" discusses hot topics from a clinician’s point of view. The journal also includes "Mini-Reviews", which allow the summary of a certain topic in no more than 1000 words.
In the summer of 2017, a new editorial team was appointed. The composition of the team reflects the diversity of the journal: Derya Tilki (Germany), and Peter Black (Canada) are primarily responsible for papers on oncology, while Richard Lee (USA) and Malte Rieken (Switzerland), will handle papers in the area of benign disease. Cathy Pierce (USA) is the Managing Editor, sharing her long-standing experience gained with European Urology.
EU Focus was started in 2015 and was the first sister journal to European Urology. The philosophy of European Urology to strive for the highest-quality scientific articles is also key for EU Focus. EU Focus publishes 6 issues per year in electronic format only. The journal is indexed in PubMed.
In 2019 European Urology Focus was accepted into the Clarivate Analytics into the Science Citation Index Expanded (SCIE), also known as SciSearch®, Journal Citation Reports/Science Edition and Current Contents®/Clinical Medicine. The following year, EU Focus was proud to announce their first impact factor of 4.827; a milestone achievement for the journal.